Skip to content

Prospective Validation of DL Model for Postoperative MACCE Prediction

Prospective Validation of Deep Learning Model to Predict Postoperative Major Adverse Cardiac and Cerebrovascular Event

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07054502
Enrollment
7000
Registered
2025-07-08
Start date
2025-07-10
Completion date
2025-12-31
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

Keywords

Deep learning, Non-cardiac surgery, Electrocardiogram, Multimodal, MACCE

Brief summary

This study aims to prospectively validate a deep learning model developed using retrospective data to predict major adverse cardiac and cerebrovascular events (MACCE) occurring within 30 days after non-cardiac surgery. The validation will be performed using prospectively collected data from patients undergoing non-cardiac surgery under general or regional anesthesia.

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 or older undergoing non-cardiac surgery under general or regional anesthesia at Seoul National University Hospital

Exclusion criteria

* Reoperation within 30 days after initial surgery * Organ procurement or pregnancy-related procedures * Ambulatory-based surgery * Preoperative tracheal intubation before entering the operating room * Surgeries performed outside the operating room

Design outcomes

Primary

MeasureTime frameDescription
Major adverse cardiovascular and cerebrovascular events (MACCE)within 30 days after surgeryOccurrence of MACCE within 30 days after surgery (composite outcome including myocardial infarction, stroke, coronary revascularization, heart failure, and death)

Countries

South Korea

Contacts

Primary ContactHyun-Kyu Yoon, MD
hyunkyu18@gmail.com82-2-2072-1146

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026